Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis.
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K, Psaltopoulou T, Wang J, Buettner S, Papalois ΑE, He J, Wolfgang CL, Pawlik TM, Weiss MJ. Margonis GA, et al. Ann Surg. 2018 Jun;267(6):1047-1055. doi: 10.1097/SLA.0000000000002552. Ann Surg. 2018. PMID: 29189379
Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
Deshwar A, Margonis GA, Andreatos N, Barbon C, Wang J, Buettner S, Wagner D, Sasaki K, Beer A, Løes IM, Pikoulis E, Damaskos C, Garmpis N, Kamphues K, He J, Kaczirek K, Poultsides G, Lønning PE, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ. Deshwar A, et al. Anticancer Res. 2018 May;38(5):2891-2895. doi: 10.21873/anticanres.12535. Anticancer Res. 2018. PMID: 29715113
Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
Masuda T, Margonis GA, Andreatos N, Wang J, Warner S, Mirza MB, Angelou A, Damaskos C, Garmpis N, Sasaki K, He J, Imai K, Yamashita YI, Wolfgang CL, Baba H, Weiss MJ. Masuda T, et al. Anticancer Res. 2018 Nov;38(11):6353-6360. doi: 10.21873/anticanres.12993. Anticancer Res. 2018. PMID: 30396957
The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
Margonis GA, Amini N, Buettner S, Kim Y, Wang J, Andreatos N, Wagner D, Sasaki K, Beer A, Kamphues C, Morioka D, Løes IM, Imai K, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Burkhart R, Endo I, Baba H, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ. Margonis GA, et al. Ann Surg. 2021 Jun 1;273(6):1165-1172. doi: 10.1097/SLA.0000000000003504. Ann Surg. 2021. PMID: 31389831
The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
Kamphues C, Kadowaki S, Amini N, van den Berg I, Wang J, Andreatos N, Sakamoto Y, Ogura T, Kakuta M, Pikouli A, Geka D, Daitoku N, Theochari M, Buettner S, Akiyama T, Antoniou E, Pikoulis E, Theodoropoulos G, Imai K, Ijzermans JNM, Margonis GA, Akagi K, Kreis ME. Kamphues C, et al. J Surg Oncol. 2021 Mar;123(4):1005-1014. doi: 10.1002/jso.26352. Epub 2020 Dec 23. J Surg Oncol. 2021. PMID: 33368279
5,131 results